Sino Medical Sciences Technology Inc. (SHA:688108)

SHA:688108 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	338.47	291.67	188.64	203.42	287.76	544.83
Cash & Short-Term Investments	338.47	291.67	188.64	203.42	287.76	544.83
Cash Growth	45.26%	54.62%	-7.27%	-29.31%	-47.18%	-15.73%
Accounts Receivable	14.81	7.47	8.94	20.28	12	66.67
Other Receivables	11.84	11.42	0.49	0.53	0.86	0.7
Receivables	26.65	18.9	9.43	20.82	12.86	67.38
Inventory	91.68	89.51	118.22	98.13	84.88	64.75
Prepaid Expenses	-	0	0.01	2.6	-	-
Other Current Assets	3.02	3.31	27.88	29.94	45.3	46.48
Total Current Assets	459.83	403.39	344.18	354.9	430.8	723.43
Property, Plant & Equipment	112.4	135.79	165.95	176.77	172.58	139.16
Long-Term Investments	-	-	14	18.95	33.65	5
Goodwill	46.22	46.22	-	-	-	2.58
Other Intangible Assets	190.11	189.31	53.4	52.87	73.92	82.07
Long-Term Deferred Tax Assets	99.7	111.88	105.33	91.78	44.17	5.86
Long-Term Deferred Charges	401.24	413.88	375.91	369.2	333.07	253.06
Other Long-Term Assets	0.22	0.08	127.05	3.14	14.89	6.34
Total Assets	1,310	1,301	1,186	1,068	1,103	1,217
Accounts Payable	24.96	13.94	20.12	13.41	8.57	20.07
Accrued Expenses	46.44	70.64	57.65	62.19	55.18	63.38
Short-Term Debt	86.47	53.05	53.55	35.54	5.01	-
Current Portion of Long-Term Debt	2.3	4.56	0.76	-	-	-
Current Portion of Leases	11.23	11.51	14.96	10.95	11.78	-
Current Income Taxes Payable	0.01	0.02	-	-	-	0.13
Current Unearned Revenue	2.78	1.87	1.12	0.79	0.41	0.79
Other Current Liabilities	17.85	36.43	3.12	9.3	11.6	7.8
Total Current Liabilities	192.03	192.02	151.27	132.18	92.56	92.18
Long-Term Debt	137	137	105.3	-	-	-
Long-Term Leases	9.59	18.99	24.92	11.83	27.49	-
Long-Term Unearned Revenue	7.76	13.32	21	2	1.94	2.48
Long-Term Deferred Tax Liabilities	38.54	40.89	20.22	22.72	21.47	17.53
Other Long-Term Liabilities	-	-	1.46	11.4	14.47	27.44
Total Liabilities	384.93	402.22	324.17	180.13	157.92	139.63
Common Stock	416.05	413.46	410	410	410	410
Additional Paid-In Capital	661.9	651.98	608.92	596.87	527.37	545.23
Retained Earnings	-185.6	-199.44	-200.94	-161.31	-8.44	122.33
Comprehensive Income & Other	1.65	0.89	1.97	1.52	-1.09	0.31
Total Common Equity	894	866.89	819.96	847.08	927.84	1,078
Minority Interest	30.79	31.45	41.69	40.4	17.33	-
Shareholders' Equity	924.79	898.34	861.65	887.48	945.16	1,078
Total Liabilities & Equity	1,310	1,301	1,186	1,068	1,103	1,217
Total Debt	246.58	225.11	199.49	58.31	44.27	-
Net Cash (Debt)	91.89	66.56	-10.85	145.11	243.48	544.83
Net Cash Growth	-	-	-	-40.40%	-55.31%	-15.73%
Net Cash Per Share	0.21	0.18	-0.03	0.36	0.60	1.33
Filing Date Shares Outstanding	416.05	413.46	410	410	410	410
Total Common Shares Outstanding	416.05	413.46	410	410	410	410
Working Capital	267.8	211.37	192.9	222.72	338.24	631.26
Book Value Per Share	2.15	2.10	2.00	2.07	2.26	2.63
Tangible Book Value	657.67	631.36	766.55	794.21	853.92	993.22
Tangible Book Value Per Share	1.58	1.53	1.87	1.94	2.08	2.42
Machinery	266.73	265.54	286	278.74	226.45	179.29
Construction In Progress	0.48	1.17	1.55	6.66	11.92	40.94

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.